期刊文献+

NO供体型香豆素-3-羧酸衍生物的合成 被引量:3

Synthesis of NO-Donating Coumarin-3-carboxylic Acid Derivatives
下载PDF
导出
摘要 以水杨醛与丙二酸二乙酯为原料制备香豆素-3-羧酸,利用其羧基与不同碳数的二溴烷烃反应得到相应的香豆素-3-羧酸溴代烷基酯,再与硝酸银反应生成香豆素-3-羧酸-硝氧烷基酯。目标化合物的结构经过红外光谱、核磁共振氢谱和质谱确证。考察了目标化合物合成中温度及投料比对反应的影响,得到最佳反应条件为:反应温度60℃,反应物配比竹(香豆素-3-羧酸溴代烷基酯):”(硝酸银)-1:3,此条件下目标化合物收率可达55.3%~90.8%。 Salicylaldehyde was reacted with diethyl malonate to give the raw material coumarin -3-carboxylic acid, which was then treated with dibromoalkanes to form brominated compounds. The brominated compounds reacted with silver nitrate to yield the target compounds. The chemical structure was confirmed by IR, MS and 1 H NMR spectroscopy. The effect of ratio of reagents and reaction temperature on the yield of the target compounds was studied. The optimum reaction conditions were as follows: n(intermediate):n(silver nitrate)= 1:3, and reaction temperature was 60℃. The yields of the target compounds were 55. 3%-90. 8%.
出处 《化学世界》 CAS CSCD 2016年第7期420-423,共4页 Chemical World
基金 安徽省教育厅自然科学重点科研项目(KJ2013A168)
关键词 香豆素-3-羧酸 香豆素-3-羧酸-硝氧烷基酯 NO供体 合成 coumarin-3-carboxylic acid nitrooxy alkyl coumarin-3-carboxylate NO donor synthesis
  • 相关文献

参考文献11

二级参考文献51

  • 1刘岩,蔡久英.冠心病危险因素的研究进展[J].心血管病学进展,2007,28(2):223-225. 被引量:51
  • 2刘秀娟,厉连斌,王歌云.香豆素-3-羧酸及其酯的合成研究[J].化学试剂,2007,29(1):43-45. 被引量:36
  • 3STUEHR DJ, KWON NS, NATHAN CF, et al. NW-Hydroxy-L- arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine[J]. JBiol Chem, 1991, 26(10): 6259-6263.
  • 4RAO CV, REDDY BS, STEELE VE, et al. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects an molecular targets [J]. Mol Cancer Ther, 2006, 5(6) :1530-1538.
  • 5WALLACE JL, MUSCARA MN, DE NUCCI G, et al. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [ 3 - [ 4- ( 2 -Fluoro-α-methyl- [ 1, 1'-biphenyl ] -4-acetyloxy ) -3 -methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester I [J ]. J Pharmacol Exp Ther, 2004, 309 (2) :626 - 633.
  • 6BERNARDO A, GASPARINI L, ONGINI E, et al. Dynamic reg- ulation of microglial functions by the non-steroidal anti-inflammatory drug NCX 2216 : implications for chronic treatments of neurodegenerative diseases [ J ]. Neurobiol Dis, 2006, 22 ( 1 ) :25 - 32.
  • 7BRUNELI,I S, SCIORATI C, D'ANTONA G, et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy[J]. Proc Natl Acad Sci USA, 2007, 104(1) :264 -269.
  • 8ABDUL-HAY SO, LUO J, ASHGHODOM RT, et al. NO-flurbiprofen reduces amyloid-beta, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade [ J ]. J Neurochem, 2009, 111 (3) :766 -776.
  • 9KARLSSON J, PIVODIC A, AGUIRRE D, et al. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee [J]. J Rheumatol, 2009, 36(6):1290-1297.
  • 10WHITE WB, SCHNITZER TJ, FLEMING R, et al. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis[J]. Am J Cardiol, 2009, 104(6) :840 -845.

共引文献72

同被引文献17

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部